CO6470871A2 - Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable. - Google Patents

Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable.

Info

Publication number
CO6470871A2
CO6470871A2 CO11168582A CO11168582A CO6470871A2 CO 6470871 A2 CO6470871 A2 CO 6470871A2 CO 11168582 A CO11168582 A CO 11168582A CO 11168582 A CO11168582 A CO 11168582A CO 6470871 A2 CO6470871 A2 CO 6470871A2
Authority
CO
Colombia
Prior art keywords
dose
oral film
unagraphable
stervosids
flavor
Prior art date
Application number
CO11168582A
Other languages
English (en)
Inventor
Jin-Kyu Park
Won-Suk Yang
Kyoung Tae Jung
Original Assignee
Chabio & Diostech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43387021&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6470871(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chabio & Diostech Co Ltd filed Critical Chabio & Diostech Co Ltd
Publication of CO6470871A2 publication Critical patent/CO6470871A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se divulga una dosis de película oral rápidamente soluble para enmascarar un sabor repugnante, en particular, una dosis de película oral rápidamente soluble que contiene un edulcorante a base de esteviósido y un edulcorante de alta potencia en una relación en peso (p/p) de 1:3 a 3:1, la cual puede enmascarar eficientemente un sabor amargo o repugnante de una medicina y puede disolverse rápidamente en la boca sin agua, mejorando en esa forma un regusto de la misma y la aceptabilidad de la dosis por parte de un paciente.
CO11168582A 2009-06-25 2011-12-07 Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable. CO6470871A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090057276 2009-06-25
KR1020100057450A KR101074271B1 (ko) 2009-06-25 2010-06-17 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름

Publications (1)

Publication Number Publication Date
CO6470871A2 true CO6470871A2 (es) 2012-06-29

Family

ID=43387021

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11168582A CO6470871A2 (es) 2009-06-25 2011-12-07 Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable.

Country Status (16)

Country Link
US (2) US20120156229A1 (es)
EP (1) EP2431028B1 (es)
JP (1) JP5539503B2 (es)
KR (1) KR101074271B1 (es)
CN (1) CN102333526B (es)
AU (1) AU2010263494A1 (es)
BR (1) BRPI1007804A2 (es)
CA (1) CA2752865C (es)
CO (1) CO6470871A2 (es)
CR (1) CR20110671A (es)
EA (1) EA021695B1 (es)
MA (1) MA33439B1 (es)
MX (1) MX2011008698A (es)
SG (1) SG176545A1 (es)
WO (1) WO2010151020A2 (es)
ZA (1) ZA201106319B (es)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2446881T3 (da) * 2003-07-24 2014-06-02 Glaxosmithkline Llc Oral opløselige film
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
JP2012031164A (ja) * 2010-07-06 2012-02-16 Teika Seiyaku Kk フィルム状製剤
CN108434089B (zh) * 2010-10-08 2020-06-16 R·P·舍勒科技有限责任公司 使用淀粉的口服疫苗快速溶解剂型
US9907759B2 (en) * 2011-02-11 2018-03-06 Ctc Bio, Inc. Sildenafil-free base-containing film preparation and method for producing same
KR101077468B1 (ko) * 2011-03-04 2011-11-07 (주)차바이오앤디오스텍 안정한 경구용 속용 필름 제제
KR101303479B1 (ko) * 2011-07-28 2013-09-06 (주)씨엘팜 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제
KR20130058160A (ko) * 2011-11-25 2013-06-04 한국유나이티드제약 주식회사 쓴맛이 차폐된 실데나필 시트레이트의 저작정 및 이의 제조방법
KR101188594B1 (ko) * 2011-12-06 2012-10-08 (주)씨엘팜 쓴맛이 차단된 실데나필 시트르산의 구강내 속붕해 필름제형
KR20130074766A (ko) * 2011-12-26 2013-07-04 에스케이케미칼주식회사 몬테루카스트 또는 이의 약학적으로 허용 가능한 염을 포함한 구강투여용 필름
KR101383430B1 (ko) * 2012-01-26 2014-04-08 광동제약 주식회사 새로운 조합의 구강내 속붕해 필름형성 조성물 및 ｐｄｅ５ 저해제가 함유된 구강내 속붕해 필름제제
EP2821066B1 (en) 2012-02-28 2018-04-25 Seoul Pharma. Co. Ltd. High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
CN102600112A (zh) * 2012-03-13 2012-07-25 北京阜康仁生物制药科技有限公司 一种以芬太尼为主药活性成分的口腔内分散溶解的膜剂
TWI594765B (zh) * 2012-04-30 2017-08-11 大塚製藥股份有限公司 口服調製劑
CN103417490B (zh) * 2012-05-21 2015-06-17 成都康弘药业集团股份有限公司 一种含有盐酸多奈哌齐的颗粒剂及其制备方法
CA2877774C (en) 2012-07-12 2017-07-18 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
KR101571670B1 (ko) 2012-08-08 2015-11-25 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제
CN102860997A (zh) * 2012-09-28 2013-01-09 天津市聚星康华医药科技有限公司 一种遮味的昂丹司琼口腔速溶膜及其制备方法
WO2014137189A1 (ko) * 2013-03-07 2014-09-12 에스케이케미칼주식회사 고함량의 약물을 함유하는 구강 붕해 필름 및 이의 제조방법
WO2014163215A1 (ko) * 2013-04-02 2014-10-09 제일약품주식회사 쓴 맛이 차폐된 약제학적 조성물
SG11201508391SA (en) * 2013-04-11 2015-11-27 Ctc Bio Inc Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer
KR102305037B1 (ko) * 2013-05-10 2021-09-24 주식회사 씨티씨바이오 도네페질 유리염기 함유 필름 제제 및 이의 제조 방법
KR101553207B1 (ko) * 2013-08-02 2015-09-17 주식회사 서울제약 도네페질 또는 그의 약제학적으로 허용되는 염을 함유한 구강붕해필름 제제 및 그의 제조방법
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
KR101516875B1 (ko) * 2013-08-21 2015-04-30 (주)우신메딕스 분산성이 개선된 실데나필 시트레이트 구강 붕해 필름 제형 및 이의 제조방법
WO2015048417A1 (en) * 2013-09-27 2015-04-02 Rohm And Haas Chemicals Llc Oral care composition
KR101428018B1 (ko) * 2013-10-18 2014-08-12 주식회사 한독 아리피프라졸 함유 구강 붕해 정제 및 이의 제조 방법
CA2931862C (en) 2013-11-08 2024-01-23 Carlos Filipe Method of stabilizing molecules without refrigeration using water soluble polymers and applications thereof in performing chemical reactions
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
KR101555908B1 (ko) 2013-12-19 2015-09-25 한미약품 주식회사 몬테루카스트 또는 이의 약제학적으로 허용 가능한 염을 포함하는 액상 제제 및 이의 제조방법
CN103750323A (zh) * 2014-01-26 2014-04-30 宁夏医科大学 一种叶黄素口腔速溶膜及其制备方法
KR101478485B1 (ko) * 2014-03-07 2014-12-31 조남훈 항산화 물질 활성 보호를 위한 프롤라민 기반 경구용 필름 제조방법
KR101489752B1 (ko) * 2014-04-28 2015-02-04 최명 도세탁셀 약물을 함유하는 구강 용해 필름형 항암제
CN104083343A (zh) * 2014-05-08 2014-10-08 万特制药(海南)有限公司 一种草酸艾司西酞普兰口腔速溶膜及其制备方法
JP6272730B2 (ja) * 2014-05-21 2018-01-31 救急薬品工業株式会社 速溶性フィルム剤
JP6748642B2 (ja) * 2014-06-24 2020-09-02 リー，キヤサリン 即効性口腔崩壊フィルム
JP6371463B2 (ja) 2014-07-17 2018-08-08 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 即時放出性乱用抑止性液体充填剤形
KR101538985B1 (ko) * 2014-09-02 2015-07-24 주식회사 서울제약 타다라필 구강붕해필름 및 이의 제조방법
CN104224756A (zh) * 2014-09-26 2014-12-24 天津市聚星康华医药科技有限公司 一种甲磺酸多沙唑嗪口腔速溶膜及其制备方法
CN104257637A (zh) * 2014-09-26 2015-01-07 天津市聚星康华医药科技有限公司 一种酮洛芬口腔速溶膜及其制备方法
KR101537263B1 (ko) * 2014-09-29 2015-07-17 주식회사 서울제약 쓴맛이 차폐된 온단세트론 구강붕해필름
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
CN104586819A (zh) * 2015-01-05 2015-05-06 万特制药(海南)有限公司 一种治疗老年痴呆病症的药物组合物及制备方法
CN104546806A (zh) * 2015-01-05 2015-04-29 万特制药(海南)有限公司 一种含有利培酮的口腔速溶膜及其制备方法
CN104586820B (zh) * 2015-01-13 2021-04-09 齐鲁制药有限公司 具有高载药量的西地那非口腔速溶薄膜组合物
KR20160139704A (ko) * 2015-05-28 2016-12-07 주식회사 씨엠지제약 아리피프라졸을 포함하는 경구용 속용 필름 제제, 및 이의 제조방법
TWI612978B (zh) * 2015-08-26 2018-02-01 口溶膜
CN105193769B (zh) * 2015-09-06 2019-02-05 合肥华方医药科技有限公司 一种盐酸苯海拉明口腔速溶膜剂的制备方法
CN106606779A (zh) * 2015-10-19 2017-05-03 浙江安吉山争医药包装科技有限公司 一种可食性膜片及其制备方法
US9949934B1 (en) * 2016-10-20 2018-04-24 Intelgenx Corp. Device and method of treating conditions associated with neuroinflammation
US20180250240A1 (en) * 2016-03-11 2018-09-06 Intelgenx Corp. Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists
RU2617238C1 (ru) * 2016-03-30 2017-04-24 Государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ЮУГМУ Минздрава России) Способ получения лекарственного средства с кислотой янтарной и цетилпиридиний хлоридом местного действия
WO2017175855A1 (en) * 2016-04-08 2017-10-12 Shionogi & Co., Ltd. Stabilized solid dosage form
CN106389392A (zh) * 2016-10-13 2017-02-15 常州市第四制药厂有限公司 一种他达拉非口腔溶膜剂及制备方法
CN106755194A (zh) * 2016-12-12 2017-05-31 青州荣美尔生物科技股份有限公司 一种超低粘度瓜尔胶的制备工艺
CN108403668B (zh) * 2017-02-10 2021-03-02 常州市第四制药厂有限公司 缬沙坦口腔崩解膜及其制备方法
JP7062368B2 (ja) * 2017-03-15 2022-05-06 武田テバファーマ株式会社 不快な味がマスキングされた経口医薬組成物
JP2020512309A (ja) * 2017-03-30 2020-04-23 インテルジェンクス コーポレーションＩｎｔｅｌｇｅｎｘ Ｃｏｒｐ． ロイコトリエン受容体拮抗薬のバイオアベイラビリティの改善のための処理方法及び装置
JP6457582B2 (ja) * 2017-04-14 2019-01-23 エルメッド エーザイ株式会社 ガランタミン含有医薬組成物、並びに医薬組成物におけるガランタミンの苦味抑制方法、及びガランタミンの苦味抑制剤
CN108926529A (zh) * 2017-05-25 2018-12-04 万特制药(海南)有限公司 盐酸帕罗西汀口服混悬液及其制备工艺
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
US20200138705A1 (en) * 2017-06-20 2020-05-07 Seattle Gummy Company Pectin gummy compostion and methods of making and using thereof
JP7391017B2 (ja) 2017-10-06 2023-12-04 カーギル インコーポレイテッド ステビオール配糖体溶解度エンハンサー
JP2019108284A (ja) * 2017-12-18 2019-07-04 エスエス製薬株式会社 経口用シート状製剤
JP2021506986A (ja) * 2017-12-20 2021-02-22 クラリア・ファルマ・ホールディング・アクチボラグ バルデナフィルを含むフィルム配合物、その調製法、およびその使用
KR20190107481A (ko) * 2018-03-12 2019-09-20 충북대학교 산학협력단 멜록시캄을 포함하는 구강붕해필름 제조방법 및 이에 의해 제조된 멜록시캄을 포함하는 구강붕해필름
CA3097222A1 (en) 2018-05-14 2019-11-21 The Procter & Gamble Company Oral care compositions comprising fluoride ions
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
RU2682623C1 (ru) * 2018-06-21 2019-03-19 Алена Евгеньевна Кормишина Композиционный энтеросорбент многоцелевого использования
GB2575625A (en) 2018-06-22 2020-01-22 Church & Dwight Co Inc Oral care compositions comprising benzocaine and mucoadhesive thin films formed therefrom
CN108743567A (zh) * 2018-08-24 2018-11-06 北京太阳升高科医药研究股份有限公司 氢溴酸加兰他敏口溶膜剂及其制备方法
CN109010323A (zh) * 2018-08-27 2018-12-18 北京普瑞博思投资有限公司 重酒石酸卡巴拉汀口溶膜剂及其制备方法
CN109010324B (zh) * 2018-08-30 2021-07-02 南京康川济医药科技有限公司 一种西地那非口溶膜剂及其制备方法
AU2019334202A1 (en) 2018-09-06 2021-03-25 Innopharmascreen, Inc. Methods and compositions for treatment of asthma or parkinson's disease
CN109106696A (zh) * 2018-09-25 2019-01-01 北京普瑞博思投资有限公司 吡仑帕奈口溶膜剂及其制备方法
CN111166730A (zh) * 2018-11-13 2020-05-19 杨守忠 盐酸金刚烷胺的速释口溶膜及其制备方法和应用
KR20200107809A (ko) 2019-03-08 2020-09-16 주식회사 씨에스파마 자일리톨 및/또는 효소처리 스테비아로 피복된 복합비타민 과립제
KR20200109775A (ko) * 2019-03-14 2020-09-23 씨제이제일제당 (주) 당전이 스테비오사이드 및 당전이 리바우디오사이드 a를 포함하는 조성물
EP3952667A1 (en) 2019-04-06 2022-02-16 Cargill, Incorporated Sensory modifiers
JP7319393B2 (ja) 2019-06-10 2023-08-01 ザ プロクター アンド ギャンブル カンパニー 製品使用結果を向上させるためにユーザフィードバック情報を生成する方法
KR102110179B1 (ko) * 2019-07-18 2020-05-13 주식회사 서울제약 타다라필 또는 그의 약제학적으로 허용되는 염 함유 구강붕해필름
KR102044515B1 (ko) 2019-08-20 2019-11-14 이영환 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법
CN111012762B (zh) * 2019-11-05 2023-03-14 浙江工业大学 一种氢溴酸加兰他敏口腔速溶膜剂及其制备方法
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
WO2022013163A1 (en) * 2020-07-14 2022-01-20 Firmenich Sa Reduction of undesirable taste notes in oral care products
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
KR102413426B1 (ko) * 2020-12-21 2022-06-29 주식회사 씨엠지제약 나라트립탄을 포함하는 구강용해 필름 제형
WO2023073922A1 (ja) * 2021-10-29 2023-05-04 日本たばこ産業株式会社 難消化デキストリンを含有するオーラル製品および当該製品用組成物
CN114366727A (zh) * 2021-12-22 2022-04-19 福建瑞泰来医药科技有限公司 苹果酸的应用、氢溴酸伏硫西汀口腔速溶膜剂及制备方法
CN114557981A (zh) * 2022-03-02 2022-05-31 山东新时代药业有限公司 一种孟鲁司特钠口腔溶膜剂及其制备工艺
WO2023173104A1 (en) * 2022-03-10 2023-09-14 Thorne Healthtech, Inc. Phospholipid-containing discs and methods of manufacture
CN117180233A (zh) * 2023-10-23 2023-12-08 力品药业(厦门)股份有限公司 一种经口腔黏膜给药的他达拉非膜剂及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000001698A (ko) * 1998-06-12 2000-01-15 김재철 쓴맛의 은폐효과가 우수한 이부프로펜 함유 약제
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
JP2000273051A (ja) * 1999-03-19 2000-10-03 Kobayashi Pharmaceut Co Ltd 苦みがマスキングされた液状製剤
US20030161879A1 (en) * 1999-06-29 2003-08-28 Shinji Ohmori Tablets quickly disintegrating in mouth
JP2001258502A (ja) * 1999-09-07 2001-09-25 Takeda Chem Ind Ltd 甘味料組成物、甘味付与方法およびその利用
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20040247649A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
DE10207394B4 (de) 2002-02-21 2007-03-29 Lts Lohmann Therapie-Systeme Ag Geschmacksmaskierte oblatenförmige Arzneizubereitung
EP1504765B1 (en) * 2002-05-16 2015-07-22 Kyukyu Pharmaceutical Co., Ltd. Quickly soluble film preparations
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
KR20040100483A (ko) * 2003-05-23 2004-12-02 애경산업(주) 활성성분 함유 구강용 필름 및 그 제조방법
KR20050048056A (ko) * 2003-11-18 2005-05-24 (주)케이비피 경구용 소모 필름 조성물
US20070110689A1 (en) * 2004-01-15 2007-05-17 Mark Feldschuh Oral anaesthetic gel
JP2005336078A (ja) * 2004-05-25 2005-12-08 Nippon Paper Chemicals Co Ltd マスキング剤
US20070116829A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Pharmaceutical Composition with High-Potency Sweetener
US20070116839A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith
TWI451728B (zh) 2006-09-29 2014-09-01 Koninkl Philips Electronics Nv 封包化系統中高速通信之具成本效益的前導碼結構
NZ575900A (en) * 2006-10-02 2012-04-27 Labtec Gmbh Non-mucoadhesive film dosage forms
WO2008049256A1 (en) * 2006-10-24 2008-05-02 Givaudan Sa Consumables
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
US20080213320A1 (en) * 2007-03-01 2008-09-04 Jeremy B. Eisenstein Compositions for treatment of gastro-esophageal reflux disorders
KR20100032883A (ko) * 2007-06-07 2010-03-26 사토 세이야쿠 가부시키가이샤 속용성 및 가요성을 가진 필름제제
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
JP5101191B2 (ja) * 2007-06-29 2012-12-19 リンテック株式会社 フィルム状製剤およびその製造方法
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
WO2009045022A2 (en) * 2007-10-03 2009-04-09 C.L. Pharm Edible film
AU2008343039B2 (en) * 2007-12-27 2014-04-24 Heartland Consumer Products, Llc Synergistic sweetening compositions
KR101163364B1 (ko) 2008-11-21 2012-07-06 주식회사 드림이엔지 자동 개폐 문비

Also Published As

Publication number Publication date
MX2011008698A (es) 2011-10-03
EP2431028B1 (en) 2017-07-12
ZA201106319B (en) 2012-05-30
KR20100138768A (ko) 2010-12-31
WO2010151020A3 (ko) 2011-05-19
US20130039932A1 (en) 2013-02-14
CN102333526B (zh) 2014-05-28
EA201270069A1 (ru) 2012-08-30
EP2431028A2 (en) 2012-03-21
JP5539503B2 (ja) 2014-07-02
MA33439B1 (fr) 2012-07-03
CN102333526A (zh) 2012-01-25
CA2752865A1 (en) 2010-12-29
CR20110671A (es) 2012-02-13
WO2010151020A2 (ko) 2010-12-29
US20120156229A1 (en) 2012-06-21
EA021695B1 (ru) 2015-08-31
EP2431028A4 (en) 2014-04-02
CA2752865C (en) 2013-11-05
AU2010263494A1 (en) 2011-08-25
JP2012528854A (ja) 2012-11-15
KR101074271B1 (ko) 2011-10-17
BRPI1007804A2 (pt) 2016-02-23
SG176545A1 (en) 2012-01-30
US9492379B2 (en) 2016-11-15

Similar Documents

Publication Publication Date Title
CO6470871A2 (es) Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable.
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
ES2660116T3 (es) Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina
EP2364144A4 (en) PHARMACEUTICAL FORM FOR ADMINISTRATION THROUGH THE MOUTH
BRPI0412752B1 (pt) Composição de filme de dissolução oral
BR112013031406A2 (pt) forma de dosagem oral comestível em tira ou disco contendo resina de troca iônica para mascarar o sabor
BRPI0414311A (pt) formas de dosagem de liberação controlada
CR10726A (es) Vacuna que comprende un adyuvante de emulsion de aceite en agua
CY1111916T1 (el) Εμβολιο ζωντανου εξασθενημενου ροταϊου για χορηγηση απο του στοματος
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
BRPI0710483B1 (pt) Dispositivo compreendendo composições com fenilefrina, cloridrato de fenilefrina, bromidrato de fenilefrina, e misturas das mesmas e Kits úteis para o tratamento de doenças respiratórias
RU2017137357A (ru) Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал
CO6382132A2 (es) Tratamiento de pirfenidona para pacientes con funcion hepatica atipica
WO2012117257A8 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
CL2011002634A1 (es) Disolucion acuosa sin alcohol etilico que comprende propanolol o una sal farmaceuticamente aceptable del mismo, un edulcorante tipo no azucarado y menos del 0,01 % (p/v) de un agente conservante; procedimiento de preparacion; uso de la disolucion en el tratamiento de hemangiomas.
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
AR084093A1 (es) Metodo para tratar los atracones o la ingesta compulsiva de alimentos; uso de buproprion y naltrexona para preparar un medicamento para dichos metodos, y composicion farmaceutica
PE20061126A1 (es) Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
ECSP12011615A (es) Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable
HRP20220691T1 (hr) Poboljšanja u i u vezi s pripravcima
AR057413A1 (es) Polvo desintegrable oralmente que comprende cilostazol
ES2706302T3 (es) Granulado de disolución rápida
Hopkins ACS chemical neuroscience molecule spotlight on Viibryd (vilazodone)
ES2714726T3 (es) Solución farmacéutica que comprende dopamina para su uso en el tratamiento de la enfermedad de Parkinson
AR051593A1 (es) Un complejo que comprende mequitazina, una ciclodextrina y un agente de interaccion

Legal Events

Date Code Title Description
FC Application refused